Podcast
MSL Talk: Tom Caravela, Hahn-Ey Lee
Insight about INSIGHTS, and how they can help your MSL career!
Summary
In this episode, Joe Liberman shares his journey from MSL to Associate Director, offering valuable advice on transitioning roles within medical affairs. He delves into the role of an Insights Lead, emphasizing the significance of MSL insights and how to effectively gather and report them. Joe discusses the impact of insights on MSL performance evaluation and provides year-end performance advice. The conversation shifts to the influence of digital tools on field medical, adaptation strategies, and the future of MSL interactions in a hybrid model. Joe concludes with reflections on the evolving role of MSLs with emerging technologies, expressing gratitude and appreciation.
Joe Liberman, Associate Director, Medical Affairs at UniQure discusses MSL insights and how they can help your career.
Joe shares…
👉 What makes a good MSL Insight and why they are so important
👉 How to effectively go about gathering Insights
👉 Best practices for reporting insights
👉 Advice on how to find success and improve performance
👉 What MSL can expect for 2022
MSL insights, medical affairs career, digital tools in field medical, hybrid MSL interactions, evolving MSL role
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Hahn-Ey Lee
Podcast
MSL Talk: Tom Caravela
A Trip Around the MSL Insights Cycle
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO